Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential cisplatin + vinorelbine followed by weekly docetaxel in advanced or metastatic NSCLC
2008-003250-15Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jul 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, vinorelbine and docetaxel in non-small cell lung cancer (NSCLC), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Time to disease progression and Safety of the sequential combination regimen. Started Jul 2008; status: completed.
02
Drugs
cisplatinvinorelbinedocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2008-003250-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003250-15.